Dergiler / The Anatolian Journal of Cardiology / 2021 / Cilt: 25 - Sayı: 1

Pulmonary hypertension in patients with sarcoidosis: A single-center experience

Sayfa
36–41
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

NT-proBNP, 6 MWD, diastolic function parameters,

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Sarcoidosis is a systemic granulomatous disease rarely complicated by pulmonary hypertension (PH).
📊
Temel Bulgular & Veri:Methods: The study included 55 patients with biopsy-proven sarcoidosis in a single center.
💡
Sonuç & Katkı:NT-proBNP, 6 MWD, diastolic function parameters,
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Sarcoidosis is a systemic granulomatous disease rarely complicated by pulmonary hypertension (PH). The prevalence of PH in sarcoidosis is unclear and has differences between ethnic groups. This study aimed to investigate the prevalence and predictors of PH in a Turkish cohort. Methods: The study included 55 patients with biopsy-proven sarcoidosis in a single center. All patients underwent detailed transthoracic echocardiography (TTE) to assess the probability of PH as recommended. Right heart catheterization (RHC) was performed for patients with intermediate–high risk of PH. Patients with mean pulmonary artery pressure >20 mm Hg by RHC were defined as PH. Demographic and clinical characteristics, laboratory data, spirometry, 6-min walk test, and TTE were compared between low and intermediate–high risk PH groups. Results: The probability of PH was low with 47 patients. Eight patients had intermediate–high probability of PH, and two of them refused to undergo RHC. Of six intermediate–high probability patients, three had PH, and all of them had post-precapillary PH. The prevalence of PH in sarcoidosis was 5.5% (3/55). Six-minute walk distance (6 MWD) and diastolic parameters (E/A ratio, E’ wave, and left atrial volume) were significantly lower, and New York Heart association class and N-terminal probrain natriuretic peptide (NT-proBNP) level were higher in intermediate–high risk PH patients compared with low-risk PH patients. Conclusion: The frequency of PH in sarcoidosis was 5.5% in a Turkish cohort. NT-proBNP, 6 MWD, diastolic function parameters,

🔖

Bu Makaleye Atıf Yap

ÖZEN, D. K., MUTLU, B., KOCAKAYA, D., TURAN, B., ŞEKERCİ, S. S., CEYHAN, B. B. (2021). Pulmonary hypertension in patients with sarcoidosis: A single-center experience. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 1, 36–41. https://ajindex.com/articles/365148

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Huitema MP, Bakker ALM, Mager JJ, Rensing BJWM, Smits F, Snijder RJ, et al. Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study. Eur Respir J 2019
  2. 1900897. [CrossRef] 2. Alhamad EH, Idrees MM, Alanezi MO, Alboukai AA, Shaik SA. Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients. Ann Thorac Med 2010
  3. 86−91. [CrossRef] 3. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005
  4. 783−8. 4. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.
  5. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005
  6. 319−38. 5. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002
  7. 111−7. [CrossRef] 6. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015
  8. 903−75. 7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015
  9. 1−39. [CrossRef] 8. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016
  10. 277−314. [CrossRef] 9. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr 2015
  11. 183−93. [CrossRef] 10. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et